BridgeBio Pharma Inc (BBIO)
24.33
-0.70
(-2.80%)
USD |
NASDAQ |
Apr 25, 16:00
24.94
+0.61
(+2.51%)
After-Hours: 07:15
BridgeBio Pharma Market Cap: 4.278B for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 4.278B |
| April 24, 2024 | 4.401B |
| April 23, 2024 | 4.477B |
| April 22, 2024 | 4.408B |
| April 19, 2024 | 4.350B |
| April 18, 2024 | 4.387B |
| April 17, 2024 | 4.392B |
| April 16, 2024 | 4.438B |
| April 15, 2024 | 4.531B |
| April 12, 2024 | 4.718B |
| April 11, 2024 | 4.987B |
| April 10, 2024 | 4.805B |
| April 09, 2024 | 4.999B |
| April 08, 2024 | 4.971B |
| April 05, 2024 | 4.941B |
| April 04, 2024 | 4.950B |
| April 03, 2024 | 5.140B |
| April 02, 2024 | 5.064B |
| April 01, 2024 | 5.271B |
| March 28, 2024 | 5.437B |
| March 27, 2024 | 5.426B |
| March 26, 2024 | 5.233B |
| March 25, 2024 | 5.168B |
| March 22, 2024 | 5.201B |
| March 21, 2024 | 5.096B |
| Date | Value |
|---|---|
| March 20, 2024 | 5.034B |
| March 19, 2024 | 4.999B |
| March 18, 2024 | 4.890B |
| March 15, 2024 | 4.846B |
| March 14, 2024 | 4.809B |
| March 13, 2024 | 4.953B |
| March 12, 2024 | 5.046B |
| March 11, 2024 | 5.089B |
| March 08, 2024 | 5.096B |
| March 07, 2024 | 5.275B |
| March 06, 2024 | 5.178B |
| March 05, 2024 | 5.205B |
| March 04, 2024 | 5.689B |
| March 01, 2024 | 6.265B |
| February 29, 2024 | 6.005B |
| February 28, 2024 | 6.205B |
| February 27, 2024 | 6.282B |
| February 26, 2024 | 6.131B |
| February 23, 2024 | 5.978B |
| February 22, 2024 | 5.908B |
| February 21, 2024 | 6.006B |
| February 20, 2024 | 6.321B |
| February 16, 2024 | 6.543B |
| February 15, 2024 | 6.898B |
| February 14, 2024 | 6.018B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
769.49M
Minimum
May 11 2022
10.77B
Maximum
Feb 08 2021
4.309B
Average
3.933B
Median
Market Cap Benchmarks
| Pfizer Inc | 142.64B |
| Alnylam Pharmaceuticals Inc | 18.10B |
| Ardelyx Inc | 1.468B |
| Regenxbio Inc | 786.82M |
| IDEAYA Biosciences Inc | 2.880B |
Market Cap Related Metrics
| PS Ratio | 425.63 |
| PEG Ratio | -0.3014 |
| Price | 24.33 |
| Earnings Yield | -16.19% |
| PEGY Ratio | -0.3014 |